Full Committee Hearing - Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
Date:
Thursday, November 15 2012, 9:45 AM
Place:
106 Dirksen Senate Office Building
Witnessesreturn to top
Panel I
-
Dr. Beth Bell , Director, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
-
Dr. Peggy Hamburg , Commissioner, Food and Drug Administration, Washington, DC
-
Dr. Lauren Smith , Interim Commissioner, Department of Public Health, Boston, MA
Panel II
-
Barry Cadden , Owner and Director of Pharmacy, New England Compounding Center, Framingham, MA
Panel III
-
Dr. Marion Kainer , Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health, Nashville, TN
-
David G. Miller , Executive Vice President and CEO, International Academy of Compounding Pharmacy, Missouri City, TX
-
Dr. Kasey K. Thompson , Vice President, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, MD
Recent News
- Harkin Statement on House Vote That Would Make College More Expensive for Millions of American Students [Chairman]
- Harkin Reintroduces FIT Kids Act to Combat Childhood Obesity and Promote Physical Activity [Chairman]
- Alexander Opposes Nominees to NLRB Who Remained on Board After Court Found Their Appointments Unconstitutional [Ranking Member]
- Senate Health Committee Passes Alexander and Colleagues’ Bill to Fix Responsibility for Safety of Sterile Compounded Drugs [Ranking Member]
- Harkin Statement on HELP Committee Approval of a Full Slate of Five Nominees to the NLRB [Chairman]
.jpg)
